ADR-001-N2

Continuous observation study after administration of ADR-001 in patients with Compensated Liver Cirrhosis

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-jRCT2033220602

Enrollment

Registered

2023-02-01

Start date

2023-02-14

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Compensated liver cirrhosis (Child-Pugh A)

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1)Patients who received at least one dose of ADR-001 in the ADR-001-N1 Study. 2)Patients capable of giving written informed consent.

Exclusion criteria

Exclusion criteria: 1)Patients decided to be ineligible for this study by the investigator.

Design outcomes

Primary

Measure	Time frame
The amount of change in Albumin-bilirubin (ALBI) score	—

Contacts

Public ContactYusuke Watanabe

Niigata University Medical and Dental Hospital

ywatanabe19840421@med.niigata-u.ac.jp+81-25-227-2207

Outcome results